Literature DB >> 33738146

Effect of Intravitreal Injections on Retinal Imaging Metrics in Glaucomatous and Non-Glaucomatous Eyes.

Ronaldo Nuesi1,2, Swarup S Swaminathan1.   

Abstract

PURPOSE OF REVIEW: To summarize the available literature on retinal imaging metrics in the context of intravitreal injections in glaucomatous and non-glaucomatous eyes. RECENT
FINDINGS: The retinal nerve fiber layer (RNFL) in injected non-glaucomatous eyes appears to thin at a similar rate to uninjected fellow eyes. A total of four studies evaluating RNFL thinning in injected glaucomatous eyes yielded mixed results, with more recent longitudinal investigations suggesting a potential association. The ganglion cell-inner plexiform layer is also being studied as a potential endpoint in both glaucomatous and non-glaucomatous eyes following intravitreal injections.

Entities:  

Keywords:  Ganglion cell layer; Ganglion cell-inner plexiform layer; Glaucoma; Intravitreal injections; Ocular hypertension; Optic nerve; Retinal nerve fiber layer

Year:  2020        PMID: 33738146      PMCID: PMC7962983          DOI: 10.1007/s40135-020-00235-z

Source DB:  PubMed          Journal:  Curr Ophthalmol Rep        ISSN: 2167-4868


  70 in total

Review 1.  SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS: What Is the Evidence?

Authors:  Vaidehi S Dedania; Sophie J Bakri
Journal:  Retina       Date:  2015-05       Impact factor: 4.256

2.  Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes.

Authors:  Jeanette Du; James T Patrie; Bruce E Prum; Peter A Netland; Yevgeniy Eugene Shildkrot
Journal:  J Glaucoma       Date:  2019-12       Impact factor: 2.503

3.  Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema.

Authors:  Nisha R Acharya; Wantanee Sittivarakul; Ying Qian; Kevin C Hong; Salena M Lee
Journal:  Retina       Date:  2011-10       Impact factor: 4.256

4.  Cirrus high-definition optical coherence tomography versus spectral optical coherence tomography/scanning laser ophthalmoscopy in the diagnosis of glaucoma.

Authors:  Kyung Min Koh; Sunyoung Jin; Young Hoon Hwang
Journal:  Curr Eye Res       Date:  2013-09-27       Impact factor: 2.424

5.  Rate of Macular Ganglion Cell-inner Plexiform Layer Thinning in Glaucomatous Eyes With Vascular Endothelial Growth Factor Inhibition.

Authors:  Won June Lee; Young Kook Kim; Yong Woo Kim; Jin Wook Jeoung; Seok Hwan Kim; Jang Won Heo; Hyeong Gon Yu; Ki Ho Park
Journal:  J Glaucoma       Date:  2017-11       Impact factor: 2.503

6.  Intravitreal injection of ranibizumab for treatment of age-related macular degeneration: effects on serum VEGF concentration.

Authors:  Xiaoya Gu; Xiaobing Yu; Hong Dai
Journal:  Curr Eye Res       Date:  2013-11-11       Impact factor: 2.424

7.  The effect of unilateral intravitreal bevacizumab (avastin), in the treatment of diffuse bilateral diabetic macular edema: a pilot study.

Authors:  Raul Velez-Montoya; Jans Fromow-Guerra; Octavio Burgos; Maurice B Landers; Virgilio Morales-Catón; Hugo Quiroz-Mercado
Journal:  Retina       Date:  2009-01       Impact factor: 4.256

8.  The long-term effect of intravitreal ranibizumab on retinal nerve fiber layer thickness in exudative age-related macular degeneration.

Authors:  Melih Parlak; F Hakan Oner; A Osman Saatci
Journal:  Int Ophthalmol       Date:  2014-07-25       Impact factor: 2.031

9.  Anterior chamber paracentesis during intravitreal injections in observational trials: effectiveness and safety and effects.

Authors:  Sandeep Saxena; Timothy Y Lai; Hideki Koizumi; Michel E Farah; Daniela Ferrara; David Pelayes; Tomohito Sato; Carsten H Meyer; Timothy Murray
Journal:  Int J Retina Vitreous       Date:  2019-03-06

10.  Real-world evidence of safety profile of intravitreal bevacizumab (Avastin) in an Indian scenario.

Authors:  Prashant Jain; Jay Sheth; Giridhar Anantharaman; Mahesh Gopalakrishnan
Journal:  Indian J Ophthalmol       Date:  2017-07       Impact factor: 1.848

View more
  2 in total

1.  Rates of RNFL Thinning in Patients with Suspected or Confirmed Glaucoma Receiving Unilateral Intravitreal Injections for Exudative AMD.

Authors:  Swarup S Swaminathan; Anne L Kunkler; Ann V Quan; Charles M Medert; Elizabeth A Vanner; William Feuer; Ta Chen Chang
Journal:  Am J Ophthalmol       Date:  2020-12-24       Impact factor: 5.488

2.  Comparison of risks of arterial thromboembolic events and glaucoma with ranibizumab and aflibercept intravitreous injection: A nationwide population-based cohort study.

Authors:  Yin-Hsi Chang; Li-Nien Chien; Wan-Ting Chen; I-Chan Lin
Journal:  PLoS One       Date:  2022-04-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.